UNIPHAR PLC (UPR.I) Stock Fundamental Analysis

DUB:UPR • IE00BJ5FQX74

4.09 EUR
-0.12 (-2.73%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Overall UPR gets a fundamental rating of 5 out of 10. We evaluated UPR against 30 industry peers in the Health Care Providers & Services industry. UPR has an excellent profitability rating, but there are concerns on its financial health. UPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year UPR was profitable.
  • In the past year UPR had a positive cash flow from operations.
  • In the past 5 years UPR has always been profitable.
  • UPR had a positive operating cash flow in each of the past 5 years.
UPR.I Yearly Net Income VS EBIT VS OCF VS FCFUPR.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.25%, UPR belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 17.78%, UPR belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
  • UPR has a Return On Invested Capital of 8.91%. This is amongst the best in the industry. UPR outperforms 83.33% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for UPR is above the industry average of 6.83%.
Industry RankSector Rank
ROA 4.25%
ROE 17.78%
ROIC 8.91%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
UPR.I Yearly ROA, ROE, ROICUPR.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

  • UPR has a Profit Margin (2.30%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of UPR has grown nicely.
  • UPR has a worse Operating Margin (3.01%) than 63.33% of its industry peers.
  • UPR's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 15.25%, UPR is in line with its industry, outperforming 43.33% of the companies in the same industry.
  • UPR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.01%
PM (TTM) 2.3%
GM 15.25%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
UPR.I Yearly Profit, Operating, Gross MarginsUPR.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UPR is creating some value.
  • UPR has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, UPR has about the same amount of shares outstanding.
  • UPR has a better debt/assets ratio than last year.
UPR.I Yearly Shares OutstandingUPR.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
UPR.I Yearly Total Debt VS Total AssetsUPR.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • An Altman-Z score of 2.70 indicates that UPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • UPR has a better Altman-Z score (2.70) than 76.67% of its industry peers.
  • A Debt/Equity ratio of 1.21 is on the high side and indicates that UPR has dependencies on debt financing.
  • UPR has a Debt to Equity ratio of 1.21. This is comparable to the rest of the industry: UPR outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 2.7
ROIC/WACC1.22
WACC7.33%
UPR.I Yearly LT Debt VS Equity VS FCFUPR.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 0.95 indicates that UPR may have some problems paying its short term obligations.
  • The Current ratio of UPR (0.95) is comparable to the rest of the industry.
  • UPR has a Quick Ratio of 0.95. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • UPR has a Quick ratio (0.65) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.65
UPR.I Yearly Current Assets VS Current LiabilitesUPR.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • UPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.84%, which is quite good.
  • The Earnings Per Share has been growing by 15.47% on average over the past years. This is quite good.
  • Looking at the last year, UPR shows a small growth in Revenue. The Revenue has grown by 7.73% in the last year.
  • The Revenue has been growing by 10.72% on average over the past years. This is quite good.
EPS 1Y (TTM)16.84%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%20.99%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%8.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.77% on average over the next years. This is quite good.
  • Based on estimates for the next years, UPR will show a small growth in Revenue. The Revenue will grow by 6.53% on average per year.
EPS Next Y14.54%
EPS Next 2Y11.05%
EPS Next 3Y10.7%
EPS Next 5Y13.77%
Revenue Next Year8.68%
Revenue Next 2Y6.85%
Revenue Next 3Y6.21%
Revenue Next 5Y6.53%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UPR.I Yearly Revenue VS EstimatesUPR.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
UPR.I Yearly EPS VS EstimatesUPR.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • UPR is valuated rather expensively with a Price/Earnings ratio of 18.59.
  • Compared to the rest of the industry, the Price/Earnings ratio of UPR is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.07. UPR is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 16.14, which indicates a correct valuation of UPR.
  • UPR's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.05, UPR is valued a bit cheaper.
Industry RankSector Rank
PE 18.59
Fwd PE 16.14
UPR.I Price Earnings VS Forward Price EarningsUPR.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • UPR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. UPR is more expensive than 60.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.67
UPR.I Per share dataUPR.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • UPR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • UPR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.28
PEG (5Y)1.2
EPS Next 2Y11.05%
EPS Next 3Y10.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • UPR has a yearly dividend return of 0.87%, which is pretty low.
  • UPR's Dividend Yield is comparable with the industry average which is at 1.55.
  • Compared to an average S&P500 Dividend Yield of 1.82, UPR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

  • On average, the dividend of UPR grows each year by 33.58%, which is quite nice.
Dividend Growth(5Y)33.58%
Div Incr Years2
Div Non Decr Years2
UPR.I Yearly Dividends per shareUPR.I Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

  • UPR pays out 7.65% of its income as dividend. This is a sustainable payout ratio.
  • UPR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP7.65%
EPS Next 2Y11.05%
EPS Next 3Y10.7%
UPR.I Yearly Income VS Free CF VS DividendUPR.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
UPR.I Dividend Payout.UPR.I Dividend Payout, showing the Payout Ratio.UPR.I Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

UNIPHAR PLC

DUB:UPR (2/27/2026, 7:00:00 PM)

4.09

-0.12 (-2.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)N/A
Inst Owners48.81%
Inst Owner ChangeN/A
Ins Owners5.09%
Ins Owner ChangeN/A
Market Cap1.06B
Revenue(TTM)2.89B
Net Income(TTM)66.31M
Analysts81.67
Price Target4.93 (20.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.02
Dividend Growth(5Y)33.58%
DP7.65%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.84%
Valuation
Industry RankSector Rank
PE 18.59
Fwd PE 16.14
P/S 0.37
P/FCF N/A
P/OCF 13.78
P/B 2.85
P/tB N/A
EV/EBITDA 11.67
EPS(TTM)0.22
EY5.38%
EPS(NY)0.25
Fwd EY6.2%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.3
OCFY7.26%
SpS11.13
BVpS1.44
TBVpS-0.75
PEG (NY)1.28
PEG (5Y)1.2
Graham Number2.67
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 17.78%
ROCE 10.46%
ROIC 8.91%
ROICexc 10.42%
ROICexgc 52%
OM 3.01%
PM (TTM) 2.3%
GM 15.25%
FCFM N/A
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
ROICexc(3y)10.45%
ROICexc(5y)10.56%
ROICexgc(3y)82.98%
ROICexgc(5y)N/A
ROCE(3y)10.62%
ROCE(5y)10.36%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.71%
ROICexc growth 5Y-1.65%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
F-Score6
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA 3.71
Cap/Depr 256.32%
Cap/Sales 3.06%
Interest Coverage 2.99
Cash Conversion 63.41%
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.65
Altman-Z 2.7
F-Score6
WACC7.33%
ROIC/WACC1.22
Cap/Depr(3y)149.63%
Cap/Depr(5y)116.24%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.5%
Profit Quality(3y)72.81%
Profit Quality(5y)95.5%
High Growth Momentum
Growth
EPS 1Y (TTM)16.84%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%20.99%
EPS Next Y14.54%
EPS Next 2Y11.05%
EPS Next 3Y10.7%
EPS Next 5Y13.77%
Revenue 1Y (TTM)7.73%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%8.62%
Revenue Next Year8.68%
Revenue Next 2Y6.85%
Revenue Next 3Y6.21%
Revenue Next 5Y6.53%
EBIT growth 1Y9.19%
EBIT growth 3Y12.44%
EBIT growth 5Y16.03%
EBIT Next Year50.49%
EBIT Next 3Y21.34%
EBIT Next 5Y16.93%
FCF growth 1Y-131.28%
FCF growth 3Y-16.24%
FCF growth 5Y-26.09%
OCF growth 1Y30.27%
OCF growth 3Y33.54%
OCF growth 5Y3.04%

UNIPHAR PLC / UPR.I FAQ

Can you provide the ChartMill fundamental rating for UNIPHAR PLC?

ChartMill assigns a fundamental rating of 5 / 10 to UPR.I.


What is the valuation status of UNIPHAR PLC (UPR.I) stock?

ChartMill assigns a valuation rating of 3 / 10 to UNIPHAR PLC (UPR.I). This can be considered as Overvalued.


What is the profitability of UPR stock?

UNIPHAR PLC (UPR.I) has a profitability rating of 7 / 10.


What is the expected EPS growth for UNIPHAR PLC (UPR.I) stock?

The Earnings per Share (EPS) of UNIPHAR PLC (UPR.I) is expected to grow by 14.54% in the next year.


Can you provide the dividend sustainability for UPR stock?

The dividend rating of UNIPHAR PLC (UPR.I) is 3 / 10 and the dividend payout ratio is 7.65%.